Indian Pharmaceutical Sector Remains Resilient Despite Market Disruptions

The Indian pharmaceutical sector remains resilient. It is maintaining stability despite recent disruptions. There are currently no plans for blanket price hikes. This stability supports the broader industry. Market conditions are being closely monitored. Pharma companies continue to navigate challenges. Regulatory stances remain consistent on pricing. The sector continues to show strength.